These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3877043)

  • 1. Drug interactions and hepatitis produced by some macrolide antibiotics.
    Pessayre D; Larrey D; Funck-Brentano C; Benhamou JP
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():181-94. PubMed ID: 3877043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
    Larrey D; Tinel M; Pessayre D
    Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
    Pessayre D
    Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
    Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
    J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
    Lindstrom TD; Hanssen BR; Wrighton SA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
    Delaforge M; Jaouen M; Mansuy D
    Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
    Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
    J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
    Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
    Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle.
    Zweers-Zeilmaker WM; Van Miert AS; Horbach GJ; Witkamp RF
    Res Vet Sci; 1999 Feb; 66(1):51-5. PubMed ID: 10088712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of macrolide antibacterials.
    Periti P; Mazzei T; Mini E; Novelli A
    Drug Saf; 1993 Nov; 9(5):346-64. PubMed ID: 8280403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
    Delaforge M; Sartori E; Mansuy D
    Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16 alpha-pregnenolone carbonitrile.
    Sartori E; Delaforge M; Mansuy D; Beaune P
    Biochem Biophys Res Commun; 1985 May; 128(3):1434-9. PubMed ID: 3873941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibacterials. Drug interactions of clinical significance.
    von Rosensteil NA; Adam D
    Drug Saf; 1995 Aug; 13(2):105-22. PubMed ID: 7576262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crossed hepatotoxicity of erythromycin propionate and troleandomycin?].
    Luherne JY; Pariente EA; Maitre F
    Gastroenterol Clin Biol; 1988 Nov; 12(11):869-70. PubMed ID: 3265396
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver.
    Fabre G; Crevat-Pisano P; Dragna S; Covo J; Barra Y; Cano JP
    Biochem Pharmacol; 1988 May; 37(10):1947-53. PubMed ID: 3259880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.